ArticleJTO clinical and research reports2022

Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC.

Patrice Desmeules et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.